celecoxib has been researched along with Infections, Respiratory in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Despite 3 years of treatment, the papillomatosis proved difficult to control, requiring a procedure approximately every 3 months." | 1.51 | Squamous Cell Papillomatosis in the Setting of Recurrent Respiratory Papillomatosis. ( Bentley, PL; Coulter, MJ; Nelson, BL, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rojas-Lechuga, MJ | 1 |
| Remacha, J | 1 |
| González-Sánchez, N | 1 |
| Grau, JJ | 1 |
| Castillo, P | 1 |
| Haag, O | 1 |
| Vilaseca, I | 1 |
| Bentley, PL | 1 |
| Coulter, MJ | 1 |
| Nelson, BL | 1 |
| Lauder, SN | 1 |
| Taylor, PR | 1 |
| Clark, SR | 1 |
| Evans, RL | 1 |
| Hindley, JP | 1 |
| Smart, K | 1 |
| Leach, H | 1 |
| Kidd, EJ | 1 |
| Broadley, KJ | 1 |
| Jones, SA | 1 |
| Wise, MP | 1 |
| Godkin, AJ | 1 |
| O'Donnell, V | 1 |
| Gallimore, AM | 1 |
| Lucs, AV | 1 |
| Wu, R | 1 |
| Mullooly, V | 1 |
| Abramson, AL | 2 |
| Steinberg, BM | 2 |
| Rosenthal, DW | 1 |
| DeVoti, JA | 1 |
| Bonagura, VR | 1 |
2 trials available for celecoxib and Infections, Respiratory
| Article | Year |
|---|---|
Constitutive overexpression of the oncogene Rac1 in the airway of recurrent respiratory papillomatosis patients is a targetable host-susceptibility factor.
Topics: Adult; Celecoxib; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Human papillomavi | 2012 |
T(H)2-like chemokine patterns correlate with disease severity in patients with recurrent respiratory papillomatosis.
Topics: Case-Control Studies; Celecoxib; Chemokines; Humans; Larynx; Papilloma; Papillomavirus Infections; P | 2012 |
3 other studies available for celecoxib and Infections, Respiratory
| Article | Year |
|---|---|
Juvenile recurrent respiratory papillomatosis treated with combined erlotinib and celecoxib: Initial report.
Topics: Adolescent; Antineoplastic Agents; Celecoxib; Child; Child, Preschool; Combined Modality Therapy; Cy | 2020 |
Squamous Cell Papillomatosis in the Setting of Recurrent Respiratory Papillomatosis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Human Papillomavirus Recombinant Vaccine Quadriv | 2019 |
Paracetamol reduces influenza-induced immunopathology in a mouse model of infection without compromising virus clearance or the generation of protective immunity.
Topics: Acetaminophen; Adaptive Immunity; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclo | 2011 |